In basic experimental research, Paige et al. found aortic rupture and death can be decreased in AAA mouse models by selectively inhibiting the IL-6 trans-signaling pathway, which suggested a possible therapeutic target (20). The gene discussed is IL6; the disease is triple-A syndrome.